These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 35726639)

  • 1. Place in therapy of anti-IL-17 and 23 in psoriasis according to the severity of comorbidities: a focus on cardiovascular disease and metabolic syndrome.
    Trovato E; Rubegni P; Prignano F
    Expert Opin Biol Ther; 2022 Dec; 22(12):1443-1448. PubMed ID: 35726639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic Syndrome and psoriatic arthritis: considerations for the clinician.
    Caso F; Chimenti MS; Navarini L; Ruscitti P; Peluso R; Girolimetto N; Del Puente A; Giacomelli R; Scarpa R; Costa L
    Expert Rev Clin Immunol; 2020 Apr; 16(4):409-420. PubMed ID: 32149545
    [No Abstract]   [Full Text] [Related]  

  • 3. Prevalence of Metabolic Syndrome in Chinese Patients With Erythrodermic Psoriasis: A Case-Control Study.
    Ma AR; Liu F; Wang R; Lin L; Wang Y; Li Q; Lu X; Du J
    Front Endocrinol (Lausanne); 2021; 12():677912. PubMed ID: 34970217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic syndrome, non-alcoholic fatty liver disease and liver stiffness in psoriatic arthritis and psoriasis patients.
    Ortolan A; Lorenzin M; Tadiotto G; Russo FP; Oliviero F; Felicetti M; D'Incà R; Favero M; Piaserico S; Doria A; Ramonda R
    Clin Rheumatol; 2019 Oct; 38(10):2843-2850. PubMed ID: 31254236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiometabolic Comorbidities in Psoriasis and Psoriatic Arthritis.
    Puig L
    Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29295598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic review and meta-analysis on prevalence of metabolic syndrome in psoriatic arthritis, rheumatoid arthritis and psoriasis.
    Loganathan A; Kamalaraj N; El-Haddad C; Pile K
    Int J Rheum Dis; 2021 Sep; 24(9):1112-1120. PubMed ID: 34076348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cardiometabolic conditions of psoriatic disease.
    Toussirot E; Gallais-Sérézal I; Aubin F
    Front Immunol; 2022; 13():970371. PubMed ID: 36159785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of tumor necrosis factor-alpha blockade on metabolic syndrome components in psoriasis and psoriatic arthritis and additional lessons learned from rheumatoid arthritis.
    Channual J; Wu JJ; Dann FJ
    Dermatol Ther; 2009; 22(1):61-73. PubMed ID: 19222518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comorbidities in psoriatic arthritis].
    Boehncke WH; Boehncke S
    Z Rheumatol; 2013 Oct; 72(8):779-83. PubMed ID: 23934051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psoriasis and metabolic syndrome: implications for the management and treatment of psoriasis.
    Wu JJ; Kavanaugh A; Lebwohl MG; Gniadecki R; Merola JF
    J Eur Acad Dermatol Venereol; 2022 Jun; 36(6):797-806. PubMed ID: 35238067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic syndrome, C-reactive protein and cardiovascular risk in psoriasis patients: a cross-sectional study.
    Paschoal RS; Silva DA; Cardili RN; Souza CDS
    An Bras Dermatol; 2018 Mar; 93(2):222-228. PubMed ID: 29723366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of cardiovascular-related comorbidity in ankylosing spondylitis, psoriatic arthritis and psoriasis in primary care: a matched retrospective cohort study.
    Ahmed N; Prior JA; Chen Y; Hayward R; Mallen CD; Hider SL
    Clin Rheumatol; 2016 Dec; 35(12):3069-3073. PubMed ID: 27485152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic syndrome in Spanish patients with psoriasis needing systemic therapy: Prevalence and association with cardiovascular disease in PSO-RISK, a cross-sectional study.
    Belinchón I; Vanaclocha F; de la Cueva-Dobao P; Coto-Segura P; Labandeira J; Herranz P; Taberner R; Juliá B; Cea-Calvo L; Puig L
    J Dermatolog Treat; 2015; 26(4):318-25. PubMed ID: 25362972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics.
    Menter A; Gottlieb A; Feldman SR; Van Voorhees AS; Leonardi CL; Gordon KB; Lebwohl M; Koo JY; Elmets CA; Korman NJ; Beutner KR; Bhushan R
    J Am Acad Dermatol; 2008 May; 58(5):826-50. PubMed ID: 18423260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive treatment of psoriatic arthritis: managing comorbidities and extraarticular manifestations.
    Ogdie A; Schwartzman S; Eder L; Maharaj AB; Zisman D; Raychaudhuri SP; Reddy SM; Husni E
    J Rheumatol; 2014 Nov; 41(11):2315-22. PubMed ID: 25362717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of Psoriatic Arthritis in Patients With Comorbidities: An Updated Literature Review Informing the 2021 GRAPPA Treatment Recommendations.
    Campanholo CB; Maharaj AB; Corp N; Bell S; Costa L; de Vlam K; Gullick NJ; Khraishi M; Kishimoto M; Palmou-Fontana N; Reddy S; Scarpa R; Vega L; Duarte GV; Zisman D; van der Windt DA; Duruoz MT; Ogdie A
    J Rheumatol; 2023 Mar; 50(3):426-432. PubMed ID: 36319003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and Safety of Biologics for Psoriasis and Psoriatic Arthritis and Their Impact on Comorbidities: A Literature Review.
    Kamata M; Tada Y
    Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32121574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psoriatic arthritis onset in psoriatic patients receiving UV phototherapy in Italy.
    Balato A; Caiazzo G; Balato N; Napolitano M;
    G Ital Dermatol Venereol; 2020 Dec; 155(6):733-738. PubMed ID: 30251803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comorbidities in patients with psoriasis.
    Gottlieb AB; Dann F
    Am J Med; 2009 Dec; 122(12):1150.e1-9. PubMed ID: 19958894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of biologic agents and other disease-modifying antirheumatic drugs on cardiovascular outcomes in psoriasis and psoriatic arthritis: a systematic review.
    Armstrong AW; Brezinski EA; Follansbee MR; Armstrong EJ
    Curr Pharm Des; 2014; 20(4):500-12. PubMed ID: 23565631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.